Browse > Article
http://dx.doi.org/10.3345/kjp.2008.51.11.1236

A case of Smith-Lemli-Opitz syndrome diagnosed by identification of mutations in the 7-dehydrocholesterol reductase (DHCR7) gene  

Park, Mee Rim (Department of Pediatrics, Asan Medical Center, University of Ulsan, College of Medicine)
Ko, Jung Min (Department of Pediatrics, Asan Medical Center, University of Ulsan, College of Medicine)
Cheon, Chong-Keun (Department of Pediatrics, Asan Medical Center, University of Ulsan, College of Medicine)
Kim, Gu-Hwan (Medical Genetics Clinic and Laboratory, Asan Medical Center, University of Ulsan, College of Medicine)
Yoo, Han-Wook (Department of Pediatrics, Asan Medical Center, University of Ulsan, College of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.51, no.11, 2008 , pp. 1236-1240 More about this Journal
Abstract
Smith-Lemli-Opitz syndrome (SLOS) is a rare, autosomal recessive disease caused by an inborn error in cholesterol synthesis. Patients with this disease suffer from multiple malformations due to reduced activity of 7-dehydrocholesterol reductase (DHCR7), which increases 7-dehydrocholesterol (7DHC) and 8-dehydrocholesterol (8DHC) concentrations and decreases cholesterol concentration in body fluids and tissue. The SLOS phenotypic spectrum ranges from a mild disorder with behavioral and learning problems to a lethal disease characterized by multiple malformations. Here, we describe a newborn male with ambiguous genitalia who was diagnosed to have type II SLOS during the neonatal period. A clinical examination revealed low levels of unconjugated estriol in the maternal serum, and a variety of fetal ultrasound anomalies, including prenatal growth retardation. After birth, the infant was diagnosed to have congenital heart disease (Tetralogy of Fallot with severe pulmonary artery stenosis), cleft lip and palate, micrognathia, postaxial polydactyly, ambiguous genitalia, and cataracts. Clinical investigation revealed extremely low plasma cholesterol levels and the presence of mutation (homozygote of p.Arg352Gln) in the DHCR7 gene. The patient underwent palliative heart surgery (to widen the pulmonary artery) and received intravenous lipid supplementation. Cholesterol levels increased slightly, but not to normal values. The patient died from cardiopulmonary failure and sepsis 72 days after birth. This report provides the first description of a Korean patient with SLOS confirmed by verification of DHCR7 gene mutation and illustrates the need for early recognition and appropriate diagnosis of this disease.
Keywords
Smith-Lemli-Opitz syndrome; Multiple malformations; 7-dehydrocholesterol reductase; Cholesterol;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Curry CJ, Carey JC, Holland JS, Chopra D, Fineman R, Golabi M, et al. Smith-Lemli-Opitz syndrome-type II: multiple congenital anomalies with male pseudohermaphroditism and frequent early lethality. Am J Med Genet 1987;26:45-57   DOI   ScienceOn
2 Bialer MG, Penchaszadeh VB, Kahn E, Libes R, Krigsman G, Lesser ML. Female external genitalia and Mullerian duct derivatives in a 46,XY infant with the SmithLemli-Opitz syndrome. Am J Med Genet 1987;28:723-31   DOI   ScienceOn
3 Fitzky BU, Witsch-Baumgartner M, Erdel M, Lee JN, Paik YK, Glossmann H, et al. Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc Natl Acad Sci U S A 1998;95:8181-6   DOI
4 Waye JS, Eng B, Nowaczyk MJ. Prenatal diagnosis of Smith-Lemli-Opitz syndrome (SLOS) by DHCR7 mutation analysis. Prenat Diagn 2007;27:638-40   DOI   ScienceOn
5 Kelley RL, Roessler E, Hennekam RC, Feldman GL, Kosaki K, Jones MC, et al. Holoprosencephaly in RSH/Smith-Lemli- Opitz syndrome: does abnormal cholesterol metabolism affect the function of Sonic Hedgehog? Am J Med Genet 1996;66:478-84   DOI   ScienceOn
6 McGaughran J, Donnai D, Clayton P, Mills K. Diagnosis of Smith-Lemli-Opitz syndrome. N Engl J Med 1994;330:1685-6; author reply 7   DOI
7 Ryan AK, Bartlett K, Clayton P, Eaton S, Mills L, Donnai D, et al. Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype. J Med Genet 1998;35:558-65   DOI
8 Cunniff C, Kratz LE, Moser A, Natowicz MR, Kelley RI. Clinical and biochemical spectrum of patients with RSH/ Smith-Lemli-Opitz syndrome and abnormal cholesterol metabolism. Am J Med Genet 1997;68:263-9   DOI   ScienceOn
9 Jezela-Stanek A, Ciara E, Malunowicz EM, Korniszewski L, Piekutowska-Abramczuk D, Popowska E, et al. Mild Smith- Lemli-Opitz syndrome: Further delineation of 5 Polish cases and review of the literature. Eur J Med Genet 2008;51:124-40   DOI   ScienceOn
10 Yu H, Lee MH, Starck L, Elias ER, Irons M, Salen G, et al. Spectrum of Delta(7)-dehydrocholesterol reductase mutations in patients with the Smith-Lemli-Opitz (RSH) syndrome. Hum Mol Genet 2000;9:1385-91   DOI   ScienceOn
11 Smith DW, Lemli L, Opitz JM. A Newly recognized syndrome of multiple congenital anomalies. J Pediatr 1964;64:210-7   DOI
12 Irons M, Elias ER, Salen G, Tint GS, Batta AK. Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome. Lancet 1993;341:1414
13 Witsch-Baumgartner M, Gruber M, Kraft HG, Rossi M, Clayton P, Giros M, et al. Maternal apo E genotype is a modifier of the Smith-Lemli-Opitz syndrome. J Med Genet 2004;41:577-84   DOI   ScienceOn
14 Witsch-Baumgartner M, Clayton P, Clusellas N, Haas D, Kelley RI, Krajewska-Walasek M, et al. Identification of 14 novel mutations in DHCR7 causing the Smith-Lemli-Opitz syndrome and delineation of the DHCR7 mutational spectra in Spain and Italy. Hum Mutat 2005;25:412
15 Loeffler J, Utermann G, Witsch-Baumgartner M. Molecular prenatal diagnosis of Smith-Lemli-Opitz syndrome is reliable and efficient. Prenat Diagn 2002;22:827-30   DOI   ScienceOn
16 Tint GS, Salen G, Batta AK, Shefer S, Irons M, Elias ER, et al. Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndrome. J Pediatr 1995;127:82-7   DOI   ScienceOn
17 Kelley RI, Hennekam RC. The Smith-Lemli-Opitz syndrome. J Med Genet 2000;37:321-35   DOI
18 Johnson JA, Aughton DJ, Comstock CH, von Oeyen PT, Higgins JV, Schulz R. Prenatal diagnosis of Smith-Lemli-Opitz syndrome, type II. Am J Med Genet 1994;49:240-3   DOI   ScienceOn
19 Correa-Cerro LS, Porter FD. 3beta-hydroxysterol Delta7- reductase and the Smith-Lemli-Opitz syndrome. Mol Genet Metab 2005;84:112-26   DOI   ScienceOn
20 Porter JA, Young KE, Beachy PA. Cholesterol modification of hedgehog signaling proteins in animal development. Science 1996;274:255-9   DOI   ScienceOn